Bacteriophage virion-associated peptidoglycan hydrolases: Potential new enzybiotics

Critical Reviews in Microbiology

Volumn 39, Issue 4, 2013, Pages 427-434

  Rodríguez Rubio, Lorena ^a   Martínez, Beatriz ^a   Donovan, David M ^b   Rodríguez, Ana ^a   García, Pilar ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antimicrobials; Biocontrol; Phage lytic proteins; Phage therapy

Indexed keywords

ANTIINFECTIVE AGENT; HYDROLASE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; VIRION ASSOCIATED PEPTIDOGLYCAN HYDROLASE;

ANTIMICROBIAL ACTIVITY; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BACTERIOLYSIS; BACTERIOPHAGE; BIOLOGICAL CONTROL AGENT; CELL SURFACE; ESCHERICHIA COLI; FOOD SAFETY; NONHUMAN; PRIORITY JOURNAL; PROTEUS VULGARIS; PSEUDOALTEROMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; PSEUDOMONAS SYRINGAE; REVIEW; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; THERMOSTABILITY; VIRION;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; FOOD PRESERVATIVES; HYDROLASES; HYDROLYSIS; PEPTIDOGLYCAN; VIRION;

EID: 84885202794     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2012.723675     Document Type: Review

References (60)

1. Abedon ST. (2011). Lysis from without. Bacteriophage, 1, 46-49
2. Bateman A, Rawlings ND. (2003). The CHAP domain: A large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci, 28, 234-237
3. Boulanger P, Jacquot P, Plançon L, Chami M, Engel A, Parquet C, Herbeuval C, Letellier L. (2008). Phage T5 straight tail fiber is a multifunctional protein acting as a tape measure and carrying fusogenic and muralytic activities. J Biol Chem, 283, 13556-13564
4. Briers Y, Lavigne R, Plessers P, Hertveldt K, Hanssens I, Engelborghs Y, Volckaert G. (2006). Stability analysis of the bacteriophage phiKMV lysin gp36C and its putative role during infection. Cell Mol Life Sci, 63, 1899-1905
5. Briers Y, Miroshnikov K, Chertkov O, Nekrasov A, Mesyanzhinov V, Volckaert G, Lavigne R. (2008). The structural peptidoglycan hydrolase gp181 of bacteriophage phiKZ. Biochem Biophys Res Commun, 374, 747-751
6. Caldentey J, Bamford DH. (1992). The lytic enzyme of the Pseudomonas phage phi 6. Purification and biochemical characterization. Biochim Biophys Acta, 1159, 44-50
7. Callewaert L, Walmagh M, Michiels CW, Lavigne R. (2011). Food applications of bacterial cell wall hydrolases. Curr Opin Biotechnol, 22, 164-171
8. Courchesne NM, Parisien A, Lan CQ. (2009). Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Pat Biotechnol, 3, 37-45
9. Clark JR, March JB. (2006). Bacteriophages and biotechnology: Vaccines, gene therapy and antibacterials. Trends Biotechnol, 24, 212-218
10. Daugelavicius R, Cvirkaite V, Gaidelyte A, Bakiene E, Gabrenaite- Verkhovskaya R, Bamford DH. (2005). Penetration of enveloped double-stranded RNA bacteriophages phi13 and phi6 into Pseudomonas syringae cells. J Virol, 79, 5017-5026
11. Delbrk M. (1940). The growth of bacteriophage and lysis of the host. J Gen Physiol, 23, 643-660
12. During K, Porsch P, Fladung M, Lörz H. (1993). Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora. Plant J, 3, 587-598
13. Fallico V, Ross RP, Fitzgerald GF, McAuliffe O. (2011). Genetic response to bacteriophage infection in Lactococcus lactis reveals a fourstrand approach involving induction of membrane stress proteins, D-alanylation of the cell wall, maintenance of proton motive force, and energy conservation. J Virol, 85, 12032-12042
14. Fenton M, Ross P, McAuliffe O, O'Mahony J, Coffey A. (2010). Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs, 1, 9-16
15. Fischetti VA. (2005). Bacteriophage lytic enzymes: Novel anti-infectives. Trends Microbiol, 13, 491-496
16. Fischetti VA. (2010). Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol, 300, 357-362
17. Fraser JS, Maxwell KL, Davidson AR. (2007). Immunoglobulin-like domains on bacteriophage: Weapons of modest damage? Curr Opin Microbiol, 10, 382-387
18. Frias MJ, Melo-Cristino J, Ramirez M. (2009). The autolysin LytA contributes to efficient bacteriophage progeny release in Streptococcus pneumoniae. J Bacteriol, 191, 5428-5440
19. García P, Martínez B, Obeso JM, Rodrïguez A. (2008). Bacteriophages and their application in food safety. Lett Appl Microbiol, 47, 479-485
20. García P, Rodrïguez L, Rodrïguez A, Martínez B. (2010). Food biopreservation: Promising strategies using bacteriocins, bacteriophages and endolysins. Trends Food Sci Tech, 21, 373-382
21. Hendrix RW, Lawrence JG, Hatfull GF, Casjens S. (2000). The origins and ongoing evolution of viruses. Trends Microbiol, 8, 504-508
22. Hermoso JA, García JL, García P. (2007). Taking aim on bacterial pathogens: Grom phage therapy to enzybiotics. Curr Opin Microbiol, 10, 461-472
23. Kanamaru S, Ishiwata Y, Suzuki T, Rossmann MG, Arisaka F. (2005). Control of bacteriophage T4 tail lysozyme activity during the infection process. J Mol Biol, 346, 1013-1020
24. Kao SH, McClain WH. (1980). Baseplate protein of bacteriophage T4 with both structural and lytic functions. J Virol, 34, 95-103
25. Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG, Norris JS. (2002). Overcoming the phage replication threshold: A mathematical model with implications for phage therapy. J Virol, 76, 5557-5564
26. Kenny JG, McGrath S, Fitzgerald GF, van Sinderen D. (2004). Bacteriophage Tuc2009 encodes a tail-associated cell walldegrading activity. J Bacteriol, 186, 3480-3491
27. Kivel HM, Daugelavicius R, Hankkio RH, Bamford JK, Bamford DH. (2004). Penetration of membrane-containing double-stranded- DNA bacteriophage PM2 into Pseudoalteromonas hosts. J Bacteriol, 186, 5342-5354
28. Lavigne R, Briers Y, Hertveldt K, Robben J, Volckaert G. (2004). Identification and characterization of a highly thermostable bacteriophage lysozyme. Cell Mol Life Sci, 61, 2753-2759
29. Leiman PG, Arisaka F, van Raaij MJ, Kostyuchenko VA, Aksyuk AA, Kanamaru S, Rossmann MG. (2010). Morphogenesis of the T4 tail and tail fibers. Virol J, 7, 355
30. Letellier L, Plançon L, Bonhivers M, Boulanger P. (1999). Phage DNA transport across membranes. Res Microbiol, 150, 499-505
31. López R, García E. (2004). Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev, 28, 553-580
32. Lu TK, Collins JJ. (2007). Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA, 104, 11197-11202
33. Lu TK, Koeris MS. (2011). The next generation of bacteriophage therapy. Curr Opin Microbiol, 14, 524-531
34. Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, Hinnebusch BJ, Buchanan SK. (2012). Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci USA, 109, 9857-9862
35. Mahony J, McAuliffe O, Ross RP, van Sinderen D. (2011). Bacteriophages as biocontrol agents of food pathogens. Curr Opin Biotechnol, 22, 157-163
36. Manoharadas S, Witte A, Bläsi U. (2009). Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus. J Biotechnol, 139, 118-123
37. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H, Imai S. (2005 Bacteriophage therapy: A revitalized therapy against bacterial infectious diseases. J Infect Chemother, 11, 211-219
38. Mindich L, Lehman J. (1979). Cell wall lysin as a component of the bacteriophage phi 6 virion. J Virol, 30, 489-496
39. Moak M, Molineux IJ. (2000). Role of the Gp16 lytic transglycosylase motif in bacteriophage T7 virions at the initiation of infection. Mol Microbiol, 37, 345-355
40. Moak M, Molineux IJ. (2004). Peptidoglycan hydrolytic activities associated with bacteriophage virions. Mol Microbiol, 51, 1169-1183
41. Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, Dong S, Donovan DM. (2012). Endolysins as antimicrobials. Adv Virus Res, 83, 299-365
42. Nishima W, Kanamaru S, Arisaka F, Kitao A. (2011). Screw motion regulates multiple functions of T4 phage protein gene product 5 during cell puncturing. J Am Chem Soc, 133, 13571-13576
43. Paul VD, Rajagopalan SS, Sundarrajan S, George SE, Asrani JY, Pillai R, Chikkamadaiah R, Durgaiah M, Sriram B, Padmanabhan S. (2011). A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein. BMC Microbiol, 11, 226
44. Piuri M, Hatfull GF. (2006). A peptidoglycan hydrolase motif within the mycobacteriophage TM4 tape measure protein promotes efficient infection of stationary phase cells. Mol Microbiol, 62, 1569-1585.
45. Rashel M, Uchiyama J, Takemura I, Hoshiba H, Ujihara T, Takatsuji H, Honke K, Matsuzaki S. (2008). Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity. FEMS Microbiol Lett, 284, 9-16
46. Ribelles P, Rodrïguez I, Suärez JE. (2012). LysA2, the Lactobacillus casei bacteriophage A2 lysin is an endopeptidase active on a wide spectrum of lactic acid bacteria. Appl Microbiol Biotechnol, 94, 101-110
47. Rodrïguez L, Martínez B, Zhou Y, Rodrïguez A, Donovan DM, García P. (2011). Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB- SauS-phiIPLA88. BMC Microbiol, 11, 138
48. Rodrïguez-Rubio L, Martínez B, Rodrïguez A, Donovan DM, García P. (2012a). Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB-SauS-phiIPLA88 HydH5 virionassociated peptidoglycan hydrolase: Gusions, deletions, and synergy with LysH5. Appl Environ Microbiol, 78, 2241-2248
49. Rodrïguez-Rubio L, Gutiérrez D, Martínez B, Rodrïguez A, Götz F, García P. (2012b). The Tape Measure Protein of the Staphylococcus aureus Bacteriophage vB-SauS-phiIPLA35 Has an Active Muramidase Domain. Appl Environ Microbiol, 78, 6369-6371
50. Rydman PS, Bamford DH. (2000). Bacteriophage PRD1 DNA entry uses a viral membrane-associated transglycosylase activity. Mol Microbiol, 37, 356-363
51. Rydman PS, Bamford DH. (2002). The lytic enzyme of bacteriophage PRD1 is associated with the viral membrane. J Bacteriol, 184, 104-110
52. Sharma M, Anand SK. (2002). Characterization of constitutive microflora of biofilms in dairy processing lines. Food Microbiol, 19, 627-636
53. Sudiarta IP, Fukushima T, Sekiguchi J. (2010). Bacillus subtilis CwlP of the SP-{beta} prophage has two novel peptidoglycan hydrolase domains, muramidase and cross-linkage digesting DD-endopeptidase. J Biol Chem, 285, 41232-41243
54. Takác M, Bläsi U. (2005). Phage P68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother, 49, 2934-2940
55. Vipra AA, Desai SN, Roy P, Patil R, Raj JM, Narasimhaswamy N, Paul VD, Chikkamadaiah R, Sriram B. (2012). Antistaphylococcal activity of bacteriophage derived chimeric protein P128. BMC Microbiol, 12, 41
56. Wattinger L, Stephan R, Layer F, Johler S. (2012). Comparison of Staphylococcus aureus isolates associated with food intoxication with isolates from human nasal carriers and human infections. Eur J Clin Microbiol Infect Dis, 31, 455-464
57. Yoong P, Schuch R, Nelson D, Fischetti VA. (2004). Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J Bacteriol, 186, 4808-4812
58. Young I, Wang I, Roof WD. (2000). Phages will out: Strategies of host cell lysis. Trends Microbiol, 8, 120-128
59. Zimmer M, Vukov N, Scherer S, Loessner MJ. (2002). The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol, 68, 5311-5317
60. Zou Y, Hou C. (2010). Systematic analysis of an amidase domain CHAP in 12 Staphylococcus aureus genomes and 44 staphylococcal phage genomes. Comput Biol Chem, 34, 251-257.